Sigma Healthcare Ltd's stock soared 5.02% during intraday trading on Thursday, following the release of its strong first-half financial results and positive business updates.

The company reported H1 revenue of AUD 5.5 billion, representing a 14.9% increase, with normalised net profit after tax rising 19.2% to AUD 392.0 million. Performance was supported by continued expansion of Chemist Warehouse and successful integration of the two businesses, with Australian Chemist Warehouse branded store sales up 17.2% and international retail network sales growing 24.5%.

Additionally, the company declared an interim dividend of 2.0 AU cents per share fully franked and noted that trading in the first seven weeks of the second half has seen growth momentum continue, while net debt decreased to AUD 635.1 million.